Chronic Obstructive Pulmonary Disease Clinical Trial
Official title:
Molecular, Cytological Features and Genetic Susceptibility of Occupational Chronic Obstructive Pulmonary Disease Attributable to Different Environmental Exposures 2.
The objective of this study is to investigate molecular, cytological and genetic features of occupational chronic obstructive pulmonary disease (COPD) in conditions of different occupational exposures. In order to achieve this goal serum pro-inflammatory cytokines and standard inflammation markers level, hemostasis, cytological analysis of bronchoalveolar lavage fluid and association of single nucleotide polymorphisms (SNPs) rs1800470 transforming growing factor β1 (TGF β1) gene, rs1828591 hedgehog interacting protein (HHIP) gene, rs4129267 interleukin 6 receptor (IL-6R) gene, rs1051730 nicotinic acetylcholine receptor 3 (CHRNA3) gene with COPD in subjects exposed to silica dust and in those exposed to polycyclic aromatic hydrocarbons exhaust will be investigated. The relationship between genotype and phenotype characteristics, such as an inflammation activity, assessed by C-reactive protein (hsCRP) and tumor necrosis factor alpha (TNF α) serum concentration, in different occupational COPD groups will be studied. The hypothesis is that the mechanisms underlying disease development and progression are different due to environmental risk factor that reflex in differs in disease attributes - molecular biomarkers, cytology results and genetic susceptibility between COPD due to dust, COPD due to chemicals and COPD in smokers therefore COPD can be subdivided into ecological phenotypes according to environmental risk factor.
Study rationale: The main risk factors of COPD are tobacco smoking, biomass smoking and
occupational factors. Tobacco smoking is well-known risk factor so tobacco induced COPD is
completely established. Nevertheless the meaning of occupational factors which are less
famous are equally important. Based on comprehensive literature review ATS endorsed the
notion that strong evidence implicates occupational factors as cause of COPD. Occupational
COPD takes 19.2 % of all COPD patients and 31.1 % of never smokers as resulted NHANESIII
study. A considerable number of work-related factors have evidence for a causal association
with COPD including (and of course not limited) silica and silicates and aromatic
hydrocarbons. Individuals in a variety of occupations and industries such as coal miners,
painters, coke workers, tunnel workers, metallurgists, welding workers, transportation
workers, builders, farmers are exposed to factors cited above. Despite this the clinical and
pathophysiological features of COPD caused by occupational factors are still unclear.
Occupational factors leading airflow limitation are various entities - vapors, dusts, gases
and fumes with different physical, chemical, biological and other features, so the
mechanisms underlying disease development and progression may be different attributable to
risk factor.
An environmental risk factors exposure as well as tobacco smoking results in COPD only in
part of the subjects which indicates the significant genome and gene environmental
interactions role. COPD develops in predisposed subjects undergoing risk factors exposure.
Therefore the risk of COPD is individual and depends on both genetic and environments. There
are few data concerning the effects of genetic on COPD risk in this specific subgroup -
people who are exposed to occupational risk factors related to the certain environmental
factor.
Statistical analysis: Statistical analysis will be carried out by Statistica 9.0 software.
Significance level will be considered p = 0.05. The qualitative variables will be expressed
as counts and percentages. The quantitative continuous variables will be expressed as means
and standard error of means (M ± m) for variables that meet the criteria of normality and
minimum and maximum, median for those that do not meet the criteria of normality.
Kruskal-Wallis test will be used for comparing multiply independent samples and Mann-Whitney
U test for comparing two independent samples if variable under consideration will continuous
and that it will be measured on an ordinal scale. For comparisons of proportions, the
Chi-square will be used.
For associations assessment we will use logistic regression method. The odds ratios (OR) and
95% confidence intervals (CI) will be calculated for each professional group. Multiple
regression model will be used to explore the relationships between demographic
characteristics, cytokine concentrations, hemostasis and airflow limitation in professional
groups.
;
Observational Model: Case Control, Time Perspective: Cross-Sectional
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05102305 -
A Multi-center,Prospective, OS to Evaluate the Effectiveness of 'NAC' Nebulizer Therapy in COPD (NEWEST)
|
||
Completed |
NCT01867762 -
An Effectiveness and Safety Study of Inhaled JNJ 49095397 (RV568) in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease
|
Phase 2 | |
Recruiting |
NCT05562037 -
Stepped Care vs Center-based Cardiopulmonary Rehabilitation for Older Frail Adults Living in Rural MA
|
N/A | |
Terminated |
NCT04921332 -
Bright Light Therapy for Depression Symptoms in Adults With Cystic Fibrosis (CF) and COPD
|
N/A | |
Completed |
NCT03089515 -
Small Airway Chronic Obstructive Disease Syndrome Following Exposure to WTC Dust
|
N/A | |
Completed |
NCT02787863 -
Clinical and Immunological Efficiency of Bacterial Vaccines at Adult Patients With Bronchopulmonary Pathology
|
Phase 4 | |
Recruiting |
NCT05552833 -
Pulmonary Adaptive Responses to HIIT in COPD
|
N/A | |
Recruiting |
NCT05835492 -
A Pragmatic Real-world Multicentre Observational Research Study to Explore the Clinical and Health Economic Impact of myCOPD
|
||
Recruiting |
NCT05631132 -
May Noninvasive Mechanical Ventilation (NIV) and/or Continuous Positive Airway Pressure (CPAP) Increase the Bronchoalveolar Lavage (BAL) Salvage in Patients With Pulmonary Diseases?
|
N/A | |
Completed |
NCT03244137 -
Effects of Pulmonary Rehabilitation on Cognitive Function in Patients With Severe to Very Severe Chronic Obstructive Pulmonary Disease
|
||
Not yet recruiting |
NCT03282526 -
Volume Parameters vs Flow Parameters in Assessment of Reversibility in Chronic Obstructive Pulmonary Disease
|
N/A | |
Completed |
NCT02546700 -
A Study to Evaluate Safety and Efficacy of Lebrikizumab in Participants With Chronic Obstructive Pulmonary Disease (COPD)
|
Phase 2 | |
Withdrawn |
NCT04446637 -
Acute Bronchodilator Effects of Ipratropium/Levosalbutamol 20/50 mcg Fixed Dose Combination vs Salbutamol 100 mcg Inhaler Plus Ipratropium 20 mcg Inhalation Aerosol Free Combination in Patients With Stable COPD
|
Phase 3 | |
Completed |
NCT04535986 -
A Phase 3 Clinical Trial to Evaluate the Safety and Efficacy of Ensifentrine in Patients With COPD
|
Phase 3 | |
Recruiting |
NCT05865184 -
Evaluation of Home-based Sensor System to Detect Health Decompensation in Elderly Patients With History of CHF or COPD
|
||
Completed |
NCT03295474 -
Telemonitoring in Pulmonary Rehabilitation: Feasibility and Acceptability of a Remote Pulse Oxymetry System.
|
||
Completed |
NCT03256695 -
Evaluate the Relationship Between Use of Albuterol Multidose Dry Powder Inhaler With an eModule (eMDPI) and Exacerbations in Participants With Chronic Obstructive Pulmonary Disease (COPD)
|
Phase 3 | |
Withdrawn |
NCT04042168 -
Implications of Appropriate Use of Inhalers in Chronic Obstructive Pulmonary Disease (COPD)
|
Phase 4 | |
Completed |
NCT03414541 -
Safety And Efficacy Study Of Orally Administered DS102 In Patients With Chronic Obstructive Pulmonary Disease
|
Phase 2 | |
Completed |
NCT02552160 -
DETECT-Register DocumEnTation and Evaluation of a COPD Combination Therapy
|